What we do Mono Pharmacare Limited markets and distributes pharmaceutical products including antibiotics, nutraceuticals, skincare, and cardiac care through contract manufacturing in India. |
Founded in 1,994 |
Market share Emerging player in Indian pharmaceutical distribution with growing revenue and strategic acquisitions. |
Problem solved Provides accessible pharmaceutical products by bridging manufacturers and retailers to meet healthcare needs across India. |
Top clients or who we serve Pharmacies, healthcare providers, and retailers across India, primarily B2B customers. |
Key management - |
Our journey and innovations Started as a partnership in 1994; became a public limited company in 2022; expanded by acquiring related distribution entities. |
Where we operate Operations primarily concentrated in India. |
Top products or what we offer Wide range of pharmaceutical drugs including antibiotics, antifungal, antacids, analgesics, and cosmetics via contract manufacturing. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue primarily recurring based on ongoing pharmaceutical distribution contracts. |
Our industry position Growing presence with 16.86% standalone revenue growth and acquisitions strengthening market position. |
Financial highlights Standalone revenue Rs. 82.64 crore with 16.86% growth; Profit after tax Rs. 3.09 crore with 26.53% growth (FY 2025). |
Geographical revenue split All revenue generated from India. |
Order book - |
Whats driving growth Expanding product portfolio, strategic acquisitions, and increased market penetration in pharmaceutical distribution. |
Our future plans Focus on consolidating acquisitions, increasing distribution reach, and enhancing product portfolio. |
Our green promise - |
Our people and values Committed to compliance, transparency, and safe workplace environment; zero tolerance for harassment. |
Key challenges ahead Ensuring board compliance, competitive industry pressures, and regulatory adherence. |
Interesting facts Transitioned from partnership to public company recently; raised funds via IPO in 2023. |
Risks and strategy Managing compliance and industry risks through strong governance and ongoing risk management practices. |
